IDH1 and IDH2 mutations have been found in other non-CNS neoplasms, including cholangiocarcinoma, acute myeloid leukemia, chondrosarcoma, and angioimmunoblastic T-cell lymphoma, but the pathogenesis in these entities remains unclear [6-8]. This evidence concerns the gene IDH1 and central nervous system neoplasm.